Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

First-trimester prenatal diagnosis by DNA analysis was found to be possible in 224 (80%) of 281 families at risk of having a child with beta-thalassaemia major. 200 prenatal diagnoses, mainly for beta-thalassaemia or sickle-cell anaemia, were made by means of chorionic villus sampling and fetal DNA analysis. The overall fetal loss rate was 6.7%, the majority being in the first half of the programme. There was one misdiagnosis. Prenatal diagnosis was also carried out successfully for both pairs of twins in two pregnancies. Comparison of these results with 53 prenatal diagnoses made with DNA prepared from amniotic fluid suggests that the first-trimester procedure is more reliable. If further experience confirms that chorionic villus sampling has an acceptably low risk for both mother and fetus it will largely replace other methods for prenatal diagnosis of the haemoglobin disorders and other single-gene conditions.

More information Original publication

DOI

10.1016/s0140-6736(86)90296-5

Type

Journal article

Publication Date

1986-10-04T00:00:00+00:00

Volume

2

Pages

763 - 767

Total pages

4

Keywords

Amniotic Fluid, Anemia, Sickle Cell, Chorionic Villi, DNA, Female, Fetal Diseases, Genes, Hemoglobinopathies, Humans, Polymorphism, Genetic, Pregnancy, Pregnancy Trimester, First, Prenatal Diagnosis, Thalassemia